Apollo Health Ventures is a company within the Venture Capital category. Apollo Health Ventures is a specialized venture capital firm and company builder that focuses on developing and investing in data-driven biotechnology and health tech startups. The firm specifically targets the biology of aging (biogerontology) and age-related diseases to extend human healthspan. Based in Berlin, it operates a 'Venture Lab' to create companies internally in addition to traditional early-stage investing.
Apollo Health Ventures was founded in 2017 and is headquartered in Berlin, Germany.
Apollo Health Ventures is part of Independent.
Apollo Health Ventures is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Apollo Health Ventures is Strong. Significant factual deltas detected.
AI models classify Apollo Health Ventures as a Challenger. AI names competitors first.
Apollo Health Ventures appeared in 5 of 7 sampled buyer-intent queries (71%). Apollo dominates queries specifically mentioning 'longevity VC' but faces stiff competition for general 'biotech venture studio' or 'age-related disease investment' searches where larger, generalist firms (like Flagship Pioneering) may appear first.
AI models accurately categorize Apollo as a leader in the longevity investment space. However, they struggle to provide real-time updates on their latest portfolio exits or exact fund sizes due to the private nature of VC data. Key gap: The specific distinction between their 'Liquid' investment funds and their 'Venture Lab' (company building) arm is often blurred in AI summaries.
Of 5 key facts verified about Apollo Health Ventures, 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The total Assets Under Management (AUM) and current fund status (e.g., Fund II vs Fund III) is often outdated or contradictory across secondary sources.
Buyers turn to Apollo Health Ventures for Angel Investing: Individual high-net-worth individuals investing directly into biotech startups., Grants and Academic Funding: Academic labs and universities spinning out research using grant money rather than private capital., among 2 documented problem areas.
Buyers evaluating Apollo Health Ventures typically ask AI models about "longevity venture capital firms Europe", "biogerontology startup investors", "best biotech company builders 2024", and 3 similar queries.
AI models suggest Angel Investing as alternatives to Apollo Health Ventures, typically when buyers ask for lower-cost, simpler, or more specialized options.
Apollo Health Ventures's core products are Venture Capital Investment (Seed/Series A), Venture Lab (Company Building).
Apollo Health Ventures uses Enterprise/Custom.
Apollo Health Ventures serves Biotechnology startups, academic researchers, institutional investors.
Apollo Health Ventures Combines a scientific 'Venture Lab' for internal company creation with a traditional investment fund specifically for longevity biotech.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/apollo-health-ventures
Last analyzed: April 11, 2026
Founded: 2017
Headquarters: Berlin, Germany